Aegis: UBS downgrades to neutral.
Babcock: Espirito Santo downgrades to neutral.Balfour Beeatty: HB Markets downgrades to hold; Deutsche Bank downgrades to hold.BG Group: Morgan Stanley downgrades to equal weight.Capital Shopping Centres: Oriel Securities upgrades to hold.Carclo: N+1 Brewin downgrades to hold.Centamin: Westhouse reiterates buy rating and 99p target.Cineworld: Investec reiterates buy rating and 272p target.
CRH: JPMorgan Cazenove downgrades to neutral.ENRC: UBS cuts target from 585p to 565p, buy rating unchanged.
Hammerson: Oriel Securities downgrades to hold.
Hikma Pharmaceuticals: Jefferies maintains buy rating and 860p target.
Melrose: UBS raises target from 242p to 260p, buy rating kept.Micro Focus: Investec maintains buy rating and 600p target; Numis downgrades to add.
Prudential: Nomura cuts target from 740p to 680p, reduce rating kept.
Rolls-Royce: Espirito Santo upgrades to fair value.
Rotork: Panmure Gordon downgrades to hold; Peel Hunt downgrades to hold.Ruukki Group: Investec maintains hold rating and 82p target.
Spirax-Sarco: Jefferies cuts target from 2,095p to 2,090p, hold rating kept.Talvivaara: Liberum Capital downgrades to hold; Seymour Pierce downgrades to hold.
Xaar: finnCap maintains buy recommendation and 320p target.BC
Balfour Beatty
Prudential
Babcock
Hikma Pharmaceuticals
Xaar
Melrose
Hammerson
Rotork
Rolls-Royce
Spirax-Sarco